Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc. | Mutual Funds

Mutual Funds that own Miraca Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
IVA Worldwide Fund
1,177,400
2.04%
487,500
0.4%
03/31/2018
T Rowe Price Overseas Stock Fund
1,135,200
1.98%
-17,500
0.2%
06/30/2018
T Rowe Price International Growth & Income Fund
1,089,500
1.9%
-7,300
0.23%
06/30/2018
Government Pension Fund - Global (The)
939,609
1.64%
-92,201
0%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
899,500
1.57%
14,300
0.04%
07/31/2018
Vanguard Total International Stock Index Fund
732,689
1.28%
0
0.01%
07/31/2018
IVA International Fund
679,800
1.19%
0
0.47%
12/31/2017
T Rowe Price International Discovery Fund
677,800
1.18%
0
0.21%
06/30/2018
Tocqueville International Value Fund (The)
587,000
1.02%
97,500
1.42%
03/29/2018
ASTON/Pictet International Fund
548,200
0.96%
0
0.73%
06/29/2018

About Miraca Holdings

View Profile
Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.